Päivi M Ojala

11PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsDisease surveillanceHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 08, 2026
Folate receptor beta targeting of tumor-associated macrophages improves lymphoma cell responses to CD19 CAR T cells.

|Mar 03, 2025
Engineered SH3-Derived Sherpabodies Function as a Modular Platform for Targeted T-cell Immunotherapy.

Rogelio A Hernández-López, Tapio Kesti, Anna R Mäkelä

|Jul 24, 2023
Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model.

Hector J Monzo, Kerttu Kalander, Marko M Hyytiäinen

|Apr 13, 2023
CAR T Cell Therapy: A Versatile Living Drug.

Rodrigo C De Marco, Hector J Monzo, Päivi M Ojala

|Jan 23, 2023
KSHV infection of endothelial precursor cells with lymphatic characteristics as a novel model for translational Kaposi's sarcoma studies.

Krista Tuohinto, Terri A DiMaio, Elina A Kiss

|Jan 22, 2021
Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres.

Timothy P Lippert, Paulina Marzec, Aurora I Idilli

Pageof 2

Frequent Collaborators

3 joint publications

Sirpa Leppä

3 joint publications

Kerttu Kalander

3 joint publications

Hector Monzo

2 joint publications

Kaisa Lehti